Company Filing History:
Years Active: 2006
Title: The Innovations of Gunnar Andersson
Introduction
Gunnar Andersson is a notable inventor based in Röstånga, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of autoimmune diseases and related conditions. His work has led to the development of innovative compounds that hold promise for clinical applications.
Latest Patents
Gunnar holds a patent for "Compounds, methods for their preparation and use thereof." This patent includes compounds of formula (I) that are designed for the clinical treatment of autoimmune diseases, inflammatory diseases, organ transplant rejection, and malignant neoplasia. The pharmaceutical composition he developed comprises a compound of formula (I) in a dosage range from 0.005 mg/kg to 10 mg/kg body weight, with a specific focus on dosages from 0.025 mg/kg to 2 mg/kg body weight. This patent highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Gunnar Andersson is associated with Active Biotech AB, a company dedicated to developing innovative therapies for serious diseases. His work at Active Biotech has been instrumental in pushing the boundaries of pharmaceutical research and development. With a patent portfolio that includes one significant patent, Gunnar has established himself as a key figure in the field.
Collaborations
Gunnar has collaborated with notable colleagues such as Stig Jönsson and Ulf Wellmar. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to advancements in their respective fields.
Conclusion
Gunnar Andersson's contributions to pharmaceutical innovation are noteworthy, particularly in the development of compounds for treating serious medical conditions. His work exemplifies the impact that dedicated inventors can have on healthcare and the importance of collaboration in driving scientific progress.